Polydipsia as another mechanism of hyponatremia after ‘ecstasy’ (3,4 methyldioxymethamphetamine) ingestion

European Journal of Emergency Medicine

Volumn 11, Issue 5, 2004, Pages 302-304

  Brvar, Miran ^a   Kozelj, Gordana ^a   Osredkar, Joško ^a   Mozina, Martin ^a   Gricar, Marko ^a   Bunc, Matjaz ^a  

^a Klini ni Center Ljubljana   (United States)

Author keywords

3; 4 methyldioxymethamphetamine; Ecstasy; Hyponatraemia; Keywords; Polydipsia; Syndrome of inappropriate antidiuretic hormone; Vasopressin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADOLESCENT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; HUMAN; HYPONATREMIA; INTENSIVE CARE; METABOLIC DISORDER; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; RISK ASSESSMENT; SCHWARTZ BARTTER SYNDROME; SUICIDE ATTEMPT;

ADOLESCENT; COMBINED MODALITY THERAPY; CRITICAL CARE; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RISK ASSESSMENT; SUICIDE, ATTEMPTED; WATER-ELECTROLYTE IMBALANCE;

EID: 14844337603     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/00063110-200410000-00014     Document Type: Article

References (15)

1. Ajaelo I, Koeing K, Snoey E. Sever hyponatraemia and inappropriate antidiuretic hormone secretion following ecstasy use. Acad Emerg Med 1998; 5:839-840.
2. Satchell SC, Connaughtoon M. Inappropriate antidiuretic hormone secretion and extreme rises in serum creatinine kinase following MDMA ingestion. Br J Hosp Med 1994; 9:495.
3. Holmes SB, Benerjee AK, Alexander WD. Hyponatreamia and seizures after ecstasy use. Postgrad Med J 1999; 75:32-33.
4. Maxwell DL, Polkey MI, Henry JA. Hyponatraemia and catatonic stupor after taking “ecstasy”. BMJ 1993; 307:1399-1400.
5. Matthai SM, Sills JA, Davidson DC, Alexandrou D. Cerebral oedema after ingestion of MDMA (“ecstasy”) and unrestricted intake of water. BMJ 1996; 312:1359.
6. Parr MJA, Low HM, Botterill P. Hyponatraemia and death after “ecstasy” ingestion. Med J Aust 1997; 166: 136-137.
7. Nuvialis X, Masclans JR, Peracaula R, de Latoree FJ. Hyponatremic coma after ecstasy ingestion. Int Clin Med 1997; 23:480-484.
8. Watson ID, Serlin M, Moncur P, Tames F. Acute hyponatraemia. Postgrad Med J 1997; 73:443-444.
9. Holden R, Jackson MA. Near-fatal hyponatremic coma due to vasopressin over-secretion after “ecstasy” (3,4-MDMA). Lancet 1996; 347:1052.
10. Sue YM, Lee YL, Huang JJ. Acute hyponatraemia, seizure, and rhabdomyolysis after ecstasy use. J Toxicol Clin Toxicol 2002; 40:931-932.
11. Lines CR, Vandormael K, Malbecq W. A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients. Pain 2001; 93:185-190.
12. Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M. Low-dose MDMA (“ecstasy”) induces vasopressin secretion. Lancet 1998; 351:1784.
13. Forsling M, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Henry JA. Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine (“ecstasy”): is metabolism a contributory factor? J Pharm Pharmacol 2001; 53:1357-1363.
14. Fallon JK, Shah D, Kicman AT, Hutt AJ, Henry JA, Cowan DA, Forsling M. Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release. Ann NY Acad Sci 2002; 965:399-409.
15. Iovino M, Steardo L. Effects of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur J Pharmacol 1985; 113:99-103.